PCR of upper respiratory specimens is the diagnostic standard for severe acute respiratory
syndrome coronavirus 2 infection. However, saliva sampling is an easy alternative to nasal …

Serological testing is emerging as a powerful tool to progress our understanding of COVID-19
exposure, transmission and immune response. Large-scale testing is limited by the need …

We investigated the dynamics of seroconversion in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. During March 29–May 22, 2020, we collected serum …

We report dynamics of seroconversion to SARS-CoV-2 infections detected by IgG ELISA in
177 individuals diagnosed by RT-PCR. Longitudinal analysis identifies 2-8.5% of individuals …

Here we describe an open and transparent consortium for the rapid development of COVID-19
rapid diagnostics tests. We report diagnostic accuracy data on the Mologic manufactured …

Background There are an abundance of commercially available lateral flow assays (LFAs)
that detect antibodies to SARS-CoV-2. Whilst these are usually evaluated by the manufacturer…

The control of the COVID-19 pandemic in the UK has necessitated restrictions on amateur
and professional sports due to the perceived infection risk to competitors, via direct person to …

Despite the availability of highly sensitive polymerase chain reaction (PCR)-based methods,
the dearth of remotely deployable diagnostic tools circumvents the early and accurate …

RT-qPCR utilising upper respiratory swabs are the diagnostic gold standard for SARS-CoV-2
despite reported low sensitivity and limited scale up due to global shortages. Saliva is a …

With reduced prevalence of visceral leishmaniasis (VL) in the Indian subcontinent (ISC), direct
and field deployable diagnostic tests are needed to implement an effective diagnostic and …